SUNRISE, Fla., Dec. 06, 2017 -- ReloQuest Inc. is proud to announce that Helen Maracle has joined the ReloQuest team as Vice President of Business Development. ReloQuest Inc. is a temporary housing platform that provides an independent, unbiased resource for global mobility, corporate clients and individuals in need of sourcing corporate housing, serviced apartments, and hotels, worldwide.
|
|||||
Photo: http://www.globenewswire.com/NewsRoom/AttachmentNg/45bdeeae-bd26-462c-87e0-68231bd89930
Helen is a forward-thinking, strategic business leader dedicated to establishing and strengthening relationships in the global mobility industry. Her accomplishments include serving as Advisor to the Board of the Southern California Relocation Council, Communications Chair for the Pacific Northwest Relocation Council and Treasurer for the Bay Area Mobility Management.
Helen will make a valuable addition to the ReloQuest team, as she brings in-depth experience from former consultative roles and a wealth of industry experience. Helen has decided to align herself with ReloQuest Inc. to be a part of an innovative company that shares a commitment to continued progress in sourcing temporary accommodations for Global Mobility. She plans to focus on providing opportunities for relocation professionals to track and optimally manage their supply chains. Helen attributes her former sales success to her level of client service and support, along with her commitment to exceed customer expectations. She will partner with clients to identify solutions to corporate housing challenges with the comprehensive ReloQuest platform.
Helen stated, “Increased supply chain globalization and complexity need to be managed effectively to mitigate risk, increase service levels, and reduce costs. I look forward to demonstrating how ReloQuest can provide valuable data leading to greater alignment with client’s business objectives; as well as, how the platform delivers better insight to service providers performance, and the strategic direction to make targeted changes for the future.”
Darin Karp, Founder and CEO of ReloQuest, said, “We are thrilled to welcome Helen to ReloQuest, her comprehensive knowledge and corporate housing experience will provide prompt and effective solutions for our clients to manage unique sourcing challenges successfully.”
About ReloQuest
ReloQuest is a universal multi-award-winning software used to source temporary accommodations, corporate housing, serviced apartments, and hotels, worldwide. ReloQuest integrates clients, suppliers, and guests throughout the process of their accommodation. The technology increases efficiency up to 80%, assists in determining best options, identifies strategic direction and impacts ROI.
Contact
Jeana Giordano
[email protected]


Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Samsung Electronics Shares Jump on HBM4 Mass Production Report
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 



